Dear Chairmen Neal and Pallone and Ranking Members Brady and Walden,
The undersigned are writing to express our appreciation for the passage of legislation to
reauthorize the Patient-Centered Outcomes Research Institute (PCORI) in your respective
Committees and urge you to finalize a long-term reauthorization of PCORI, maintain its current
funding sources, and continue its mandate to conduct comparative clinical effectiveness research
(CER). The Friends of PCORI Reauthorization is a coalition of 183 patient and family caregiver
organizations, health provider associations, biopharma/life science companies, payers, and other
interested entities and individuals supportive of PCORI’s patient-centered mission and
reauthorization.
While the PCOR Trust fund was extended through November 21st in the Continuing Resolution (H.R.
4378/ PL 116-59), it did not extend the funding mechanisms for PCORI to receive FY2020 funds
during this short extension. Without this funding, PCORI will be unable to fund new research and its
ongoing operations will be negatively impacted. Our priority is to ensure that long-term and
consistent funding for PCORI be reauthorized. However, we also urge that if there is another shortterm extension, PCORI’s funding streams be continued as well.
Read full letter here
